The purpose of this study is to investigate advanced epithelial tumors. This study is focused on understanding how the investigational medication works in individuals with this condition.
This study evaluates the safety and tolerability of the investigational medication. Researchers are looking at how participants respond to the treatment.
- Who can participate: Adults aged 18 and older with advanced epithelial cancer can participate if they have a progressive disease and meet specific health criteria.
- Study details: Participants will receive the investigational treatment in cycles. In some cases, participants may receive a placebo, which is an inactive substance that looks like the investigational treatment but does not contain any medicine.
How understandable was the trial content above?
Hard to understand
Easy to understand